EP3351620
- Application Number
- EP18161278A
- Filing Date
- Oct 10, 2014
- Status
- Revoked
- Apr 22, 2022
- Grant Date
- Sep 2, 2020
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP3351620B1 was granted to Regeneron Pharmaceuticals on Sep 2, 2020 following the initial filing on Oct 10, 2014 under the application number EP18161278A . The current legal status of the patent is Revoked.
AI Generated Summary New
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents